VOXZOGO™ (vosoritide) earned U.S. Food and Drug Administration (FDA) approval on November 19, 2021, as the first therapeutic treatment for Achondroplasia. Pediatric orthopaedic surgeon Daniel
...
![Christian A. Farley Nieves](/sites/default/files/styles/4_3/public/2022-02/220207_SOM_Scholarship_Nieves-028-800x450.jpg?itok=g1MdQlMK)
Awards and Honors
Grateful Tiger Conversation: Christian A. Farley Nieves
(2/23/22) Christian A. Farley Nieves Medical School Development Gifts Fund Utuado, Puerto Rico First-year student
...
More than 250,000 people undergo a transurethral procedure each year in the U.S., and up
...
Continuous positive airway pressure (CPAP) is the treatment of choice for moderate-to-severe obstructive sleep apnea
...
(2/3/22) First delta, then omicron. The latest Covid variants have spread like wildfire across the
...
An international peer-reviewed medical journal examining global research trends in obstructive sleep apnea (OSA) found
...
(1/28/22) Researchers at the University of Missouri and the University of Minnesota have discovered how
...
(1/27/22) Professor Lee-Ann H. Allen at the University of Missouri School of Medicine has been
...